文献速递细胞病理与分子病理

形态学验证:既定分类方案可依据恶性风险对涎腺细胞学进行可靠分层且观察者间一致性显著

Putting morphology to the test: An established classification scheme reliably stratifies salivary gland cytology by risk of malignancy with substantial interobserver agreement.
PubMed 文献 · Cancer Cytopathol · 2020-11-02

本研究基于169例有手术随访的涎腺细针穿刺细胞学病例,由4名阅片者按Griffith等提出的形态学亚分类标准独立分类,以多数意见为共识,计算观察者间一致性(IOA)和恶性风险(ROM)。结果显示总体一致性显著(κ=0.69),MOMuc、OGV、PO和MBHy一致性较高,PB和MOCyst一致性轻微;PB、PO、MOMuc和OGV的ROM高,后两者可能最好归为可疑恶性。

要点

  • 总体IOA显著(κ=0.69),MOMuc、OGV、PO和MBHy一致性较高。
  • PB和MOCyst一致性轻微(κ分别为0.11和0.18),标准可能需修订。
  • PB、PO、MOMuc和OGV的ROM高,MOMuc和OGV可能最好归为可疑恶性。

核心结论

  • Griffith等提出并纳入米兰系统的涎腺细针穿刺细胞学分类方案总体一致性显著,其中MOMuc、OGV、PO和MBHy一致性尤其高。
  • PB和MOCyst一致性轻微,可能需修订标准改进;PB、PO、MOMuc和OGV的ROM高,后两者可能最好归为可疑恶性。

研究设计与样本

  • 研究纳入169例有手术随访的涎腺细针穿刺细胞学病例,由4名阅片者按Griffith等标准分类,以多数意见为共识。

主要发现

  • 基底样肿瘤ROM:PB为100%(1/1例),MBHy为71.4%(5/7例),MBFib为50.0%(3/6例),MBOther为47.4%(9/19例)。
  • 嗜酸细胞样肿瘤ROM:OGV为100%(10/10例),MOMuc为92.3%(12/13例),PO为88.9%(8/9例),MOOther为33.3%(5/15例),MOCyst为0(0/1例)。
  • 总体IOA κ=0.69;基底样肿瘤IOA:MBHy κ=0.59,MBFib κ=0.41,MBOther κ=0.41,PB κ=0.11。
  • 嗜酸细胞样肿瘤IOA:MOMuc κ=0.88,OGV κ=0.67,PO κ=0.63,MOOther κ=0.57,MOCyst κ=0.18。

关键数值与推荐

  • 基底样肿瘤亚分类:多形性(PB)、单形性伴纤维基质(MBFib)、伴透明基质(MBHy)、伴其他基质(MBOther)。
  • 嗜酸细胞样肿瘤亚分类:多形性(PO)、颗粒和/或空泡状胞质(OGV)、单形性伴黏液背景(MOMuc)、伴囊性背景(MOCyst)、伴其他背景(MOOther)。

临床怎么用

  • 该分类方案可依据ROM对涎腺细胞学进行风险分层,其中MOMuc和OGV高ROM提示可能应归为可疑恶性。
  • PB和MOCyst一致性低,解读时应谨慎,可能需要修订标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology describes several salivary gland fine-needle aspiration cytology (SGFNAC) morphologies developed by Griffith et al. Basaloid neoplasms are pleomorphic (PB) or monomorphic with fibrillary (MBFib), hyaline (MBHy), or other (MBOther) matrix. Oncocytoid neoplasms can be pleomorphic (PO), demonstrate granular and/or vacuolated cytoplasm (OGV), or be monomorphic with mucinous (MOMuc), cystic (MOCyst), or other (MOOther) background. In the current study, the authors explore interobserver agreement (IOA) and risk of malignancy (ROM) for these subcategories. METHODS: The study included 169 SGFNAC cases with surgical follow-up. Four reviewers categorized these cases using the criteria of Griffith et al. with consensus determined by majority. For all morphologic categories, IOA (using the Fleiss kappa) and ROM were calculated. RESULTS: ROMs for basaloid categories were: PB: 100% (1 of 1 case); MBHy: 71.4% (5 of 7 cases); MBFib: 50.0% (3 of 6 cases); and MBOther: 47.4% (9 of 19 cases). ROMs for oncocytoid neoplasms were: OGV: 100% (10 of 10 cases); MOMuc: 92.3% (12 of 13 cases); PO: 88.9% (8 of 9 cases); MOOther: 33.3% (5 of 15 cases); and MOCyst: 0 (0 of 1 case). The system demonstrated substantial agreement overall (κ = 0.69). For basaloid neoplasms, the IOA results were: MBHy: κ = 0.59; MBFib: κ = 0.41; MBOther: κ = 0.41; and PB: κ = 0.11. For oncocytoid neoplasms, the IOA results were: MOMuc: κ = 0.88; OGV: κ = 0.67; PO: κ = 0.63; MOOther: κ = 0.57; and MOCyst: κ = 0.18. CONCLUSIONS: The SGFNAC scheme proposed by Griffith et al. and incorporated into the Milan System for Reporting Salivary Gland Cytopathology demonstrated substantial agreement overall, with particularly high agreement for the MOMuc, OGV, PO, and MBHy categories. The PB and MOCyst categories demonstrated slight agreement and may be improved by revised criteria. The PB, PO, MOMuc, and OGV categories demonstrated high ROM, and the latter 2 categories might best be classified as suspicious for malignancy.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Lubin DJ, Griffith CC, Buonocore DJ, et al. Putting morphology to the test: An established classification scheme reliably stratifies salivary gland cytology by risk of malignancy with substantial interobserver agreement. Cancer Cytopathol. 2020. PMID: 33136345. doi:10.1002/cncy.22382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。